Indirect comparison meta-analysis of aspirin therapy after coronary surgery - Wikidata - wikimedia - TriplyDB

Indirect comparison meta-analysis of aspirin therapy after coronary surgery

Indirect comparison meta-analysis of aspirin therapy after coronary surgery

http://www.wikidata.org/entity/Q28166364

about

Aspirin dosage for the prevention of graft occlusion in people undergoing coronary surgery The role of twice versus three times daily heparin dosing for thromboembolism prophylaxis in general medical patients admitted to the hospital The role of twice versus three times daily heparin dosing for thromboembolism prophylaxis in general medical patients admitted to the hospital Effects of aspirin and clopidogrel on plasma brain natriuretic peptide in patients with heart failure receiving ACE inhibitors Biological efficacy of low versus medium dose aspirin after coronary surgery: results from a randomized trial [NCT00262275]'Lost in translation': accounting for between-country differences in the analysis of multinational cost-effectiveness data.Indirect comparisons: a review of reporting and methodological quality Expert position paper on the management of antiplatelet therapy in patients undergoing coronary artery bypass graft surgery Treatment of Adults With Treatment-Resistant Depression: Electroconvulsive Therapy Plus Antidepressant or Electroconvulsive Therapy Alone? Evidence From an Indirect Comparison Meta-Analysis.Safety and efficacy outcomes of preoperative aspirin in patients undergoing coronary artery bypass grafting: a systematic review and meta-analysis.Belgian guidelines for economic evaluations: second edition.Vein graft failure: from pathophysiology to clinical outcomes.The ABC of non-inferiority margin setting from indirect comparisons.On-pump Cardiac Surgery Enhances Platelet Renewal and Impairs Aspirin Pharmacodynamics: Effects of Improved Dosing Regimens.

P2860

Q24186070-6EC22CD4-63A6-488C-B383-9D0317964C30 Q24200910-CDADA692-293A-4C09-83DD-50F3699D0A99 Q24242045-362575B0-C5EF-4B29-B5B9-066E48C0779C Q28200166-E6AF63D1-F6D9-48D6-8F59-5B79E925CEF5 Q28218286-BB6B74C9-9E5C-44F9-A722-FC36CC041077 Q33261643-3C447192-293B-4312-A89A-B24140010C60 Q33750311-6580FE63-FE8E-4074-8079-3512B398F914 Q33755419-DB5F4530-C976-47AA-9BBF-D024D67BE8BA Q35857837-466ABB71-D304-45CF-A8D2-9330326A53A7 Q38161373-9DB9CB95-6795-4D72-AAAB-3F7388CC324C Q38393706-9A509EC3-DC10-4D55-908D-B6EED981D8ED Q38837879-1E832DB2-E308-4E76-8813-50F083E4A4CC Q44224597-DD51BB11-28C7-45BC-9D3F-D0968BDF6DC3 Q51070680-E2240E3B-40E1-4253-9B87-B023FDC7AA95

P2860

Indirect comparison meta-analysis of aspirin therapy after coronary surgery

http://www.wikidata.org/entity/Q28166364

description

2003 nî lūn-bûn

@nan

2003 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Indirect comparison meta-analysis of aspirin therapy after coronary surgery

@ast

Indirect comparison meta-analysis of aspirin therapy after coronary surgery

@en

Indirect comparison meta-analysis of aspirin therapy after coronary surgery

@nl

type

label

Indirect comparison meta-analysis of aspirin therapy after coronary surgery

@ast

Indirect comparison meta-analysis of aspirin therapy after coronary surgery

@en

Indirect comparison meta-analysis of aspirin therapy after coronary surgery

@nl

prefLabel

Indirect comparison meta-analysis of aspirin therapy after coronary surgery

@ast

Indirect comparison meta-analysis of aspirin therapy after coronary surgery

@en

Indirect comparison meta-analysis of aspirin therapy after coronary surgery

@nl

P1433

Q28166364-327918AD-5CBA-4A3E-B4DB-FFA36A7A6389

P1476

Q28166364-944B7051-75A6-4916-9EA9-6F1F46FB13E9

P2093

Q28166364-04829F60-A8F1-4392-B5B9-68638C545D18

Q28166364-0946A8BF-BB44-4520-9066-A4D51C722600

Q28166364-09EBA6FC-B798-4246-B0CE-717E96729516

Q28166364-38BE1F82-DF74-4853-A217-268EC711BB47

Q28166364-FC402BC0-2F86-498E-A3AC-8F7F7A0165D2

P2860

Q28166364-03CA5262-9C62-47F1-B35D-0B9865DE5149

Q28166364-08C0BCEF-9B19-45CB-B105-BC7D4177C93A

Q28166364-0C47BE47-F7F9-46E3-9A8F-527FDB41B191

Q28166364-0C92C4CB-773D-4802-9D1C-4EB5A4AA3F5D

Q28166364-1F348F59-C310-4A38-9C61-F7ED2A41E2D4

Q28166364-20AADD5D-7B5D-436F-A1B5-5F5F16FD8D72

Q28166364-278F4E16-93FF-4779-8498-7EB2A6EECF50

Q28166364-4D256A1F-16BC-411B-81C7-7B105EF47E50

Q28166364-5074CF7C-37B2-42BB-A79A-68FFB0332B70

Q28166364-5342E2A3-6063-4D73-88AB-6BA74C4C6870

P304

Q28166364-29CA5C99-525D-4147-98D9-CABB99E15869

P31

Q28166364-0751e189-394f-4f6a-930b-2da809c61f0b

Q28166364-08B1B106-E617-4E66-A493-03C7E20CDBD1

Q28166364-61A59BDD-6194-4037-9843-1D0E18743AF7

P356

Q28166364-24DCA6D7-C7F4-4D47-9426-E75F5F140527

P407

Q28166364-D98EC609-0838-4CD9-BBDA-4B4CCFD31CA3

P433

Q28166364-9985ED27-23B4-44C8-92DA-0810B5E6AF67

P478

Q28166364-23190EFF-A571-42BF-AE89-1D10A3B3D7BF

P50

Q28166364-B54E431A-F607-4DE7-A555-83635A062A1D

Q28166364-DC5F7736-604F-449D-8351-7C2ACA98AC38

P577

Q28166364-9BE6DBC9-77D3-436C-A33A-73FAE2942318

P5875

Q28166364-C2CA1B67-B229-498B-B130-54A48AB72C87

P698

Q28166364-7A0AAD39-04F1-42CC-A161-A4AAFB887F27

P921

Q28166364-37A522A0-D6F8-4C86-80BD-FA0D419CA369

Q28166364-CB931689-BB5F-4C32-BD2D-8E10CD0F42F1

P932

Q28166364-C93F25B3-FDFA-456D-9D22-45A30F61EFFE

P356

BMJ.327.7427.1309

P1433

P1476

Indirect comparison meta-analysis of aspirin therapy after coronary surgery

@en

P2093

Ayyaz Ali

http://www.w3.org/2001/XMLSchema#string

Lyn Edmonds

http://www.w3.org/2001/XMLSchema#string

Stephen Large

http://www.w3.org/2001/XMLSchema#string

Tom Routledge

http://www.w3.org/2001/XMLSchema#string

Ziad Ali

http://www.w3.org/2001/XMLSchema#string

P2860

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

Aspirin resistance after coronary artery bypass grafting

Active-control trials: how would a new agent compare with placebo? A method illustrated with clopidogrel, aspirin, and placebo

Platelet-active drugs : the relationships among dose, effectiveness, and side effects

Aspirin and mortality from coronary bypass surgery

The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials

Interaction revisited: the difference between two estimates

Indirect comparison in evaluating relative efficacy illustrated by antimicrobial prophylaxis in colorectal surgery.

Effect of dipyridamole and aspirin on late vein-graft patency after coronary bypass operations.

Low-dose acetylsalicylic acid (100 mg/day) after aortocoronary bypass surgery: a placebo-controlled trial.

P304

1309

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/BMJ.327.7427.1309

http://www.w3.org/2001/XMLSchema#string

P407

P433

7427

http://www.w3.org/2001/XMLSchema#string

P478

327

http://www.w3.org/2001/XMLSchema#string

P50

Douglas G. Altman

P577

2003-12-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8974874

http://www.w3.org/2001/XMLSchema#string

P698

14656836

http://www.w3.org/2001/XMLSchema#string

P921

cardiac surgery

P932

286307

http://www.w3.org/2001/XMLSchema#string